Dr. Sindhu Kilaru is a trained Medical Oncologist with expertise in the diagnosis and management of various solid organ cancers, including breast, ovarian, lung, and colon cancers. She is committed to providing compassionate, personalized, and evidence-based cancer care to every patient. With advanced training in Medical Oncology and experience across leading medical institutions, Dr. Sindhu combines clinical expertise with the latest advancements in cancer treatment. Her professional experience also includes multidisciplinary collaboration with surgical oncology, radiation oncology, pathology, and other specialties to support comprehensive cancer care. With a strong interest in medical research, she has contributed to peer-reviewed international publications and presented her research at national and international oncology conferences. She remains dedicated to integrating the latest evidence-based practices into patient care. Her approach is centered on compassionate care, clear communication, and a commitment to helping every patient navigate their cancer journey with confidence.
Clinical Skills
Medical Oncology & Cancer Management
Solid Organ Cancer Care
Breast & Ovarian Cancer Management
Lung & Colon Cancer Management
Evidence-Based Cancer Treatment
Multidisciplinary Oncology Care
Tumor Board Participation
Onco-Pathology Collaboration
Clinical Research & Oncology Trials
Patient-Centered Cancer Care
Clinical Interests
Breast & Ovarian Cancers
Lung Cancer
Colon Cancer
Immunotherapy
Cancer Research
Molecular & Precision Oncology
Education
DM – Medical Oncology, SOA University, Bhubaneswar – 2022
MD – Internal Medicine, JSS Academy of Higher Education & Research, Mysore – 2019
MBBS, Siddhartha Medical College, Vijayawada – 2015
Professional Memberships
American Society of Clinical Oncology (ASCO)
European Society for Medical Oncology (ESMO)
Indian Society of Medical and Pediatric Oncology (ISMPO)
Indian Cooperative Oncology Network (ICON)
Papers and Publications
PD-L1 Expression in Head & Neck Cancer – 2024
PD-L1 Expression in Advanced Lung Cancer – 2024
Immune Checkpoint Inhibitors in India – 2024
Next-Generation Sequencing in Oncology – 2024
ALK Inhibitor Resistance in Lung Cancer – 2023
Extranodal NK/T-Cell Lymphoma – 2022
Gestational Choriocarcinoma – 2022
Cutaneous DLBCL – 2021
Primary Gastric Hodgkin’s Lymphoma – 2020
Neuroendocrine Carcinoma of Gallbladder – 2020
Zinc Deficiency & Supplementation – 2020
Languages known
English, Telugu, Tamil and Hindi
“Every patient deserves compassionate care, honest guidance, and my complete commitment to their journey.”
